Children’s Cancer Research Fund Marks Decade of Progress and $64 Million in Strategic Investments During Childhood Cancer Awareness Month
admin The arrival of September marks the annual observance of Childhood Cancer Awareness Month, a period...
admin
Celebrating Frank Gioscia’s Remarkable Journey for Childhood Cancer Research.
Frank Gioscia, a 73-year-old resident of the Great Smoky Mountains region, has achieved a historic...
Setbacks Emerge for Pioneering CAR-T Therapies in Autoimmune Diseases as Clinical Trials Face Safety Pauses
The promising frontier of harnessing powerful CAR-T cell therapies, long lauded for their transformative impact...
ESC Congress Unveils Pivotal Cardiovascular Trial Data, Reshaping Treatment Paradigms and Market Dynamics
The annual congress of the European Society of Cardiology (ESC), a preeminent global event in...
CureSearch for Children’s Cancer Appoints Fisher Phillips Chairman John Polson to Board of Directors
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
Alumis’s Envudeucitinib Fails to Meet Primary Endpoints in Phase 2b Lupus Trial, Shares Plunge Amid Broader TYK2 Inhibitor Challenges
Alumis, a biopharmaceutical company focused on precision immunology, faced a significant setback on September 1,...
Novartis’s Remibrutinib Emerges as a Differentiated BTK Inhibitor, Evading Liver Safety Concerns Plaguing Rivals in the Autoimmune Landscape
Novartis has announced a significant breakthrough in the development of its investigational Bruton’s Tyrosine Kinase...
Moments That Matter: The Evolution of Childhood Cancer Advocacy and the Search for Normalcy
September marks the annual observance of Childhood Cancer Awareness Month, a period traditionally defined by...
CureSearch Names Dr. John Prensner as 2025 Young Investigator Awardee to Advance Research in Atypical Teratoid Rhabdoid Tumors
The landscape of pediatric oncology is poised for a significant shift as CureSearch for Children’s...
Mid-cap biotechs join Trump’s latest round of drug pricing deals
In a significant development for the U.S. pharmaceutical landscape, the Trump administration on Monday announced...
